HopeStage
Back to all studies
TerminatedNCT05095792

Effect of Ketamine on Neurological Activity as Measured by Electroencephalogram (EEG)

Observational studyAges 21–60United StatesDepression
The study in practice

Understand this study

Who could participate?

Listed age limits: 21 years to 60 years.

Listed locations
AustinSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: November 9, 2021
Recruitment status
Terminated
Enrollment listed in the registry
1
Sponsor
Entheon Biomedical Corp.
Sponsor type
Other organization
Study type
Observational
Intervention type
Other
Locations
United States
Age range
From 21 Years to 60 Years
Official registry ID
NCT05095792
Official title
Show the full official title

Evaluation of the Effect of Ketamine on Neurological Activity as Measured by Quantitative EEG

Recruitment & locations

Terminated

Austin

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Entheon Biomedical Corp.

Who can participate?

Listed age limits: 21 years to 60 years.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies